| NBGTX | VIGAX | NBGTX / VIGAX | |
| Total Expense Ratio | 1.01 | 0.05 | 2,020% |
| Annual Report Gross Expense Ratio | 1.01 | 0.05 | 2,020% |
| Fund Existence | 32 years | 25 years | - |
| Gain YTD | 15.048 | 19.785 | 76% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.67B | 357B | 1% |
| Annual Yield % from dividends | 0.00 | 0.41 | 0% |
| Returns for 1 year | 8.04 | 18.50 | 43% |
| Returns for 3 years | 54.98 | 110.85 | 50% |
| Returns for 5 years | 34.86 | 99.11 | 35% |
| Returns for 10 years | 61.53 | 349.19 | 18% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GSAOX | 19.46 | 0.34 | +1.78% |
| Goldman Sachs Small Cap Gr Insghts A | |||
| MSGSX | 17.52 | 0.23 | +1.33% |
| MassMutual Small Cap Gr Eq R5 | |||
| FVSKX | 58.73 | 0.74 | +1.28% |
| Fidelity Value Strategies K | |||
| HCACX | 27.33 | 0.15 | +0.55% |
| Hartford Capital Appreciation C | |||
| SHPAX | 22.04 | -0.04 | -0.18% |
| Saratoga Health & Biotechnology A | |||